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New therapeutic approaches that can accelerate neutrophil apoptosis under
inflammatory conditions to enhance the resolution of inflammation are now under
study. Neutrophils are deprived of proliferative capacity and have a tightly
controlled lifespan to avoid their persistence at the site of injury. We have recently
described that the proliferating cell nuclear antigen (PCNA), a nuclear factor
involved in DNA replication and repair of proliferating cells is a key regulator of
neutrophil survival. The nuclear-to-cytoplasmic relocalization occurred during
granulocytic differentiation and is dependent on a nuclear export sequence thus
strongly suggesting that PCNA has physiologic cytoplasmic functions. In this
review, we will try to put into perspective the physiologic relevance of PCNA in
neutrophils. We will discuss key issues such as molecular structure, post-
translational modifications, based on our knowledge of nuclear PCNA, assuming
that similar principles governing its function are conserved between nuclear and
cytosolic PCNA. The example of cystic fibrosis that features one of the most intense
neutrophil-dominated pulmonary inflammation will be discussed. We believe that
through an intimate comprehension of the cytosolic PCNA scaffold based on nuclear
PCNA knowledge, novel pathways regulating neutrophil survival can be unraveled
and innovative agents can be developed to dampen inflammation where it proves
detrimental.
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